checkAd
    Startseite > Aktien > Celyad Oncology > Nachrichten
    Celyad Oncology Aktie
    0,6000
     
    USD
    0,00 %
    0,0000 USD
    Letzter Kurs 26.10.23 Nasdaq OTC
    ISIN: US1512052002 · WKN: A14VMC · SYM: CYADY · Belgien

    Neueste Nachrichten

    Celyad Oncology Reports Full Year 2023 Financial Results and Recent Business Highlights
    04.04.24 · Business Wire (engl.) · Celyad Oncology
    Celyad Oncology announces intention to terminate SEC reporting obligations
    08.02.24 · globenewswire · Celyad Oncology
    Celyad Oncology Announces Intention to Terminate SEC Reporting Obligations
    08.02.24 · Business Wire (engl.) · Celyad Oncology
    Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook
    16.01.24 · globenewswire · Celyad Oncology
    Celyad Oncology Provides Fourth Quarter 2023 Business Update and 2024 Outlook
    16.01.24 · Business Wire (engl.) · Celyad Oncology
    Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
    20.12.23 · globenewswire · Celyad Oncology
    Celyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLC
    20.12.23 · Business Wire (engl.) · Celyad Oncology
    Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
    15.12.23 · globenewswire · Celyad Oncology
    Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
    15.12.23 · Business Wire (engl.) · Celyad Oncology
    Celyad Announces Management Change
    04.12.23 · Business Wire (engl.) · Celyad Oncology
    Celyad Oncology SA: Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)
    30.11.23 · Business Wire (engl.) · Celyad Oncology
    Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)
    21.11.23 · globenewswire · Celyad Oncology